Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

President Donald Trump announced 25% tariffs on all goods imported from Canada and Mexico and a 10% levy on China on Saturday ...

Jefferies maintains a Buy rating on JB Pharma citing strong CDMO growth potential and a 34% upside. Know more about it.

Jefferies analyst Blayne Curtis reiterated a Buy rating on Astera Labs, Inc. (ALAB – Research Report) yesterday. The company’s shares closed ...

Brent Thill, Jefferies, joins 'Fast Money' to talk Palantir and where the stock goes from here after record run.

Jefferies analyst Julien Dormois maintained a Hold rating on Demant (WILLF – Research Report) today and set a price target of DKK265.00. The ...

Jefferies reaffirms 'Buy' on ONGC, citing growth from BP partnership and policy changes. Target price: Rs 375. Read more now.

These healthcare REITs are rated Buy at Jefferies and make sense now for investors seeking dependable passive income and a ...

Jefferies maintained a Buy rating on Cognizant Technology Solutions (NASDAQ:CTSH) stock and increased the price target to ...

Jefferies expects the debt requirements to peak in fiscal 2025-27 at 1.4 times net debt versus one times in the previous ...

Investing.com -- SSAB (ST: SSABa )'s share price saw a notable recovery after investment bank Jefferies upgraded its rating ...

Jefferies Financial Group Inc. hired Tim Kerry from Barclays Plc as the bank builds up its ranks to prepare for a wave of M&A ...